HIGHFDA DEVICE

Theken Companies Recalls 409 iNSitu Bipolar Hip System Heads for Sterile Barrier Risk (2025)

Theken Companies recalled 409 iNSitu Bipolar Hip System bipolar head implants distributed nationwide in New Jersey, Pennsylvania and Texas. The devices failed transit testing and may have a compromised sterile barrier. Hospitals and surgeons should stop using the device and follow recall instructions.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
September 11, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
September 11, 2025
Hazard Level
HIGH
Brand
Theken Companies
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Theken Companies
Product type
Bipolar Head Assembly
Model numbers
10-22-0038, 10-22-0040, 10-22-0042, 10-22-0044, 10-22-0046, 10-22-0048, 10-22-0050, 10-22-0052
Sizes
38mm, 40mm, 42mm, 44mm, 46mm +7 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 11, 2025

  2. Reported by FDA DEVICE

    October 29, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Downstream recall for RES 97605, BioPro femoral components. Product failed transit testing. Impacted product may have potential issues with sterile barrier.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Theken Companies LLC or your healthcare provider for instructions. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

About This Product

The iNSitu Bipolar Hip System is used in hip replacement procedures. The bipolar head assembly is a component that articulates with the acetabular cup during joint replacement.

Why This Is Dangerous

A transit testing failure raises concerns about the sterile barrier integrity. If the barrier is breached, there is a risk of infection or implant-associated complications.

Industry Context

This recall is not indicated as part of a broader industry pattern.

Real-World Impact

Hospitals and patients may experience delays in device availability and require medical team coordination to replace affected components. No injuries have been reported yet.

Practical Guidance

How to identify if yours is affected

  1. Review model numbers 10-22-0038 through 10-22-0052 in your inventory.

Where to find product info

UDI-DI numbers and lot codes are printed on device packaging and labeling. Model numbers are on the device itself or accompanying documentation.

What timeline to expect

Recall processing and notices are expected to continue in the coming weeks. Recipients should follow the manufacturer’s instructions and coordinate in

If the manufacturer is unresponsive

  • Escalate to hospital risk management or the FDA recall hotline if the manufacturer is not responsive.
  • Consider contacting state health authorities if necessary.

How to prevent similar issues

  • Verify UDI-DI against recall lists before using hip implant components.
  • Maintain an updated inventory of hip prosthesis components and their recall status.
  • Coordinate with procurement to retire affected stock and obtain compliant replacements.

Documentation advice

Document all recall communications, inventory recalls, and any patient-level actions taken. Retain photos, letters, and receipts related to the recall.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • US nationwide distribution; NJ, PA, TX
  • Recall date 2025-09-11; Report date 2025-10-29

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
10-22-0038
10-22-0040
10-22-0042
10-22-0044
10-22-0046
+3 more
Affected States
ALL
Report Date
October 29, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more